Literature DB >> 21677900

Reward-seeking behavior in human narcolepsy.

Alexandra Dimitrova1, Rolf Fronczek, Janneke Van der Ploeg, Thomas Scammell, Shiva Gautam, Alvaro Pascual-Leone, Gert Jan Lammers.   

Abstract

STUDY
OBJECTIVES: The hypocretin system enhances signaling in the mesolimbic pathways regulating reward processing and addiction. Because individuals with narcolepsy with cataplexy have low hypocretin levels, we hypothesized that they may be less prone to risk- and reward-seeking behaviors, including substance abuse.
DESIGN: Endpoints were performance on an array of psychometric tests (including the Eysenck Impulsiveness Scale, the Zuckerman Sensation Seeking Scale, the Gormally Binge Eating Scale, and the Beck Depression and Anxiety Inventory) and on the Balloon Analogue Risk Task (BART).
SETTING: Tertiary narcolepsy referral centers in Leiden (The Netherlands) and Boston (USA). PATIENTS: Subjects with narcolepsy with cataplexy (n = 30), narcolepsy without cataplexy (n = 15), and controls (n = 32) matched for age, sex, and smoking behavior.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: There was no difference in risk-taking behavior between narcolepsy with or without cataplexy and the control group, as measured using the BART and the array of questionnaires. However, subjects in the narcolepsy with cataplexy group had significantly higher scores on the Eysenck Impulsiveness Scale (p < 0.05), with 10.0% categorized as impulsive, compared to 6.7% of the narcolepsy without cataplexy group and none of the controls. Narcoleptics with cataplexy also scored significantly higher than controls on the Binge Eating Scale (p < 0.05), with moderate or severe binge eating in 23%. On the depression and anxiety scales, all narcolepsy patients, especially those with cataplexy, scored significantly higher than controls.
CONCLUSIONS: We found that narcoleptics with or without cataplexy generally have normal risk-taking behavior, but narcoleptics with cataplexy were more impulsive and more prone to binge eating than patients without cataplexy and controls. Our findings shed new light on the relation between sleepiness and impulsiveness. Furthermore, rates of depression and anxiety were higher in all narcoleptic subjects. However, using the current methods, no evidence could be found to support the hypothesis that hypocretin deficiency would affect reward-processing in humans.

Entities:  

Keywords:  Narcolepsy; addiction; cataplexy; hypocretin; orexin; reward-seeking; risk-taking; sleep; sleepiness; substance abuse

Mesh:

Year:  2011        PMID: 21677900      PMCID: PMC3113969          DOI: 10.5664/JCSM.1076

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  45 in total

1.  Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART).

Authors:  C W Lejuez; Jennifer P Read; Christopher W Kahler; Jerry B Richards; Susan E Ramsey; Gregory L Stuart; David R Strong; Richard A Brown
Journal:  J Exp Psychol Appl       Date:  2002-06

2.  Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats.

Authors:  Stephanie L Borgland; Robert C Malenka; Antonello Bonci
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

3.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

4.  The CAGE questionnaire: validation of a new alcoholism screening instrument.

Authors:  D Mayfield; G McLeod; P Hall
Journal:  Am J Psychiatry       Date:  1974-10       Impact factor: 18.112

5.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

6.  CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.

Authors:  Takashi Kanbayashi; Yuichi Inoue; Shigeru Chiba; Rika Aizawa; Yasushi Saito; Haruko Tsukamoto; Yukiharu Fujii; Seiji Nishino; Tetsuo Shimizu
Journal:  J Sleep Res       Date:  2002-03       Impact factor: 3.981

7.  The socioeconomic impact of narcolepsy.

Authors:  Richard Dodel; Helga Peter; Tobias Walbert; Annika Spottke; Carmen Noelker; Karin Berger; Uwe Siebert; Wolfgang H Oertel; Karl Kesper; Heinrich F Becker; Geert Mayer
Journal:  Sleep       Date:  2004-09-15       Impact factor: 5.849

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects.

Authors:  Ronald M Salomon; Beth Ripley; John S Kennedy; Benjamin Johnson; Dennis Schmidt; Jamie M Zeitzer; Seiji Nishino; Emmanuel Mignot
Journal:  Biol Psychiatry       Date:  2003-07-15       Impact factor: 13.382

10.  The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice.

Authors:  Ingrid Olssøn; Arnstein Mykletun; Alv A Dahl
Journal:  BMC Psychiatry       Date:  2005-12-14       Impact factor: 3.630

View more
  20 in total

1.  Effect of psychostimulants on impulsivity and risk taking in narcolepsy with cataplexy.

Authors:  Sophie Bayard; Muriel Croisier Langenier; Yves Dauvilliers
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

Review 2.  Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.

Authors:  Mathieu Nollet; Samuel Leman
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

3.  Childhood onset narcolepsy cataplexy-more than just a sleep disorder.

Authors:  Suresh Kotagal; Seema Kumar
Journal:  Sleep       Date:  2013-02-01       Impact factor: 5.849

4.  The link between OSA and depression: another reason for integrative sleep medicine teams.

Authors:  Patricia Haynes
Journal:  J Clin Sleep Med       Date:  2013-05-15       Impact factor: 4.062

Review 5.  Orexin/Hypocretin System: Role in Food and Drug Overconsumption.

Authors:  Jessica R Barson; Sarah F Leibowitz
Journal:  Int Rev Neurobiol       Date:  2017-08-08       Impact factor: 3.230

Review 6.  Medical comorbidity of binge eating disorder.

Authors:  Pablo Olguin; Manuel Fuentes; Guillermo Gabler; Anna I Guerdjikova; Paul E Keck; Susan L McElroy
Journal:  Eat Weight Disord       Date:  2016-08-23       Impact factor: 4.652

Review 7.  Sleep and Eating Disorders.

Authors:  Kelly C Allison; Andrea Spaeth; Christina M Hopkins
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

8.  Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression.

Authors:  Mathieu Nollet; Philippe Gaillard; Arnaud Tanti; Virginie Girault; Catherine Belzung; Samuel Leman
Journal:  Neuropsychopharmacology       Date:  2012-06-20       Impact factor: 7.853

Review 9.  Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior.

Authors:  Jessica R Barson
Journal:  Brain Res       Date:  2018-08-17       Impact factor: 3.252

10.  Correlates to Problem Behaviors in Pediatric Narcolepsy: A Pilot Study.

Authors:  Althea Robinson Shelton; Beth Malow
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.